Advertisement

Topics

Vitae Pharmaceuticals Company Profile

12:24 EDT 27th March 2017 | BioPortfolio

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery programs. Vitae's goal is to discover, develop and commercialize innovative new medicines that will be best-in-class for important disease areas, such as cardiovascular diseases, cancer and dermatology.We are focused on the development of compounds for high value, well validated biological targets. In our discovery and development processes, we seek to leverage available existing clinical and / or preclinical knowledge to efficiently and effectively create novel drug candidates that can address clear unmet therapy needs. Vitae's unique product engine combines the drug discovery skills of proven, deeply experienced drug hunters with state-of-the-art proprietary drug design technologies. This integrated and entrepreneurial approach improves the quality and innovativeness of the compounds we discover, while dramatically shortening the time required to bring them to the clinic.We have demonstrated the ability to rapidly advance novel compounds into clinical development, as Vitae now has clinical candidates in three therapeutic areas, two of which are in clinical studies and a pipeline of additional promising compounds.

Location

502 West Office Center
Drive Fort Washington
Pennsylvania
19034
United States of America

Contact

Phone: (215) 461-2000
Fax: (215) 461-2006
Email: contact@vitaepharma.com


News Articles [1000 Associated News Articles listed on BioPortfolio]

Vitae Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...

BRIEF-Allergan successfully completes Vitae tender offer

* Allergan successfully completes Vitae tender offer Source text for Eikon: Further company coverage:

Allergan discloses Phase II miss in LXR program

Allergan plc (NYSE:AGN) said VTP-38543 did not show proof of concept in a Phase II trial to treat atopic dermatitis. Allergan acquired the liver X receptor beta (NR1H2; LXR-b) agonist via its $639 mil...

Vitae Pharmaceuticals Inc VTAE Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250

SummaryVitae Pharmaceuticals Inc Vitae Pharmaceuticals is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with...

Vitae Pharmaceuticals Inc VTAE Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 27022017] Prices from USD $250

SummaryVitae Pharmaceuticals Inc Vitae Pharmaceuticals is a biopharmaceutical company that offers pharmaceutical products. The company discovers and develops and small molecule drugs for diseases with...

Advisory Committees: US FDA Gets Out Of The Redaction Business

Panel members’ curricula vitae will now be released without a review and redaction of potentially confidential information; FDA’s policy change...   

Sharon Kleyne & Dr. Gregory H Tefft Tell Audience How to Look Great & Live to 150

Grants Pass, OR (PRWEB) November 23, 2016 Date aired: November 21st, 2016 Guest: Dr. Gregory H. Tefft, Chief Science Officer for ...

Allergan Successfully Completes Vitae Tender Offer

DUBLIN, Oct. 25, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the successful completion of Allergan's tender offer to purchase all outstandin...

Drugs and Medications [0 Results]

None

PubMed Articles [157 Associated PubMed Articles listed on BioPortfolio]

Progress Confirmed for Pharmaceuticals in 2016.

n/a.

Temporal and spatial behavior of pharmaceuticals in Narragansett Bay, Rhode Island, United States.

The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Status of pharmaceuticals in African water bodies: Occurrence, removal and analytical methods.

In this review paper, the milestones and challenges that have been achieved and experienced by African Environmental Scientists regarding the assessment of water pollution caused by the presence of ph...

Clinical Trials [26 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

The aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy with bleomycin in treatment of primary liver tumors in clinical study phase I and II. The study will ...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 200 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 200 mg (Apsen Pharmaceuticals A / S.) after single dose oral administration to healthy subjects of both sexes, u...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 300 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 300 mg (Apsen Pharmaceuticals A / S.), after single dose oral administration to healthy subjects of both sexes, ...

Companies [1251 Associated Companies listed on BioPortfolio]

Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets, including...

Vitae Pharmaceuticals

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery pr...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Vitae Pharmaceuticals" on BioPortfolio

We have published hundreds of Vitae Pharmaceuticals news stories on BioPortfolio along with dozens of Vitae Pharmaceuticals Clinical Trials and PubMed Articles about Vitae Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vitae Pharmaceuticals Companies in our database. You can also find out about relevant Vitae Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record